Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow References
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Disclaimer
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Jackson, G.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Jackson, G.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


Tibolone and the cardiovascular system

G. Jackson*

Shirley Oaks Hospital, Croydon, Surrey, U.K.

* Correspondence: Dr G. Jackson, MD, FRCP, FESC, FASC, Shirley Oaks Hospital, Poppy Lane, Croydon, Surrey CR0 8AB, U.K.

Abstract

Tibolone has a number of beneficial effects on the cardiovascular system. It increases fibrinolysis without significantly altering coagulation parameters. It stimulates cardiac output, blood flow and vessel relaxation, and has no adverse effects on glucose/insulin metabolism. Clinical studies in healthy postmenopausal women and those with hypertension have revealed no adverse effects on blood pressure, whereas there is preliminary evidence of anti-ischaemic effects in women with angina. Finally, it has beneficial effects on serum triglyceride and lipoprotein(a) levels, although levels of high-density lipoprotein cholesterol are also reduced. Thus, the evidence points toward an overall beneficial effect of tibolone on cardiovascular risk.

Key Words: Blood pressure • cardiovascular • coagulation • hormone replacement therapy • lipids • tibolone


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J Am Coll CardiolHome page
R. Campisi, J. Camilletti, A. Mele, J. Erriest, P. Pedroni, and A. Guiglioni
Tibolone Improves Myocardial Perfusion in Postmenopausal Women With Ischemic Heart Disease: An Open-Label Exploratory Pilot Study
J. Am. Coll. Cardiol., February 7, 2006; 47(3): 559 - 564.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.